Medtronic plc (MDT) — Analyst outlook / Analyst consensus target is. Based on 49 analyst ratings, the consensus is bullish — 1 Strong Buy, 26 Buy, 22 Hold.
The consensus price target is $111.45 (low: $100.00, high: $120.00), representing an upside of 26.5% from the current price $88.12.
Analysts estimate Earnings Per Share (EPS) of $5.20 and revenue of $32.22B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.77 vs est $5.20 (missed -46.7%). 2025: actual $3.63 vs est $5.46 (missed -33.5%). Analyst accuracy: 31%.
MDT Stock — 12-Month Price Forecast
$111.45
▲ +26.48% Upside
Average Price Target
Based on 49 Wall Street analysts offering 12-month price targets for Medtronic plc, the average price target is $111.45, with a high forecast of $120.00, and a low forecast of $100.00.
The average price target represents a +26.48% change from the last price of $88.12.
Highest Price Target
$120.00
Average Price Target
$111.45
Lowest Price Target
$100.00
MDT Analyst Ratings
Buy
Based on 49 analysts giving stock ratings to Medtronic plc in the past 3 months
EPS Estimates — MDT
31%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $2.77
vs Est $5.20
▼ 87.6% off
2025
Actual $3.63
vs Est $5.46
▼ 50.3% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — MDT
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $32.364B
vs Est $32.221B
▲ 0.4% off
2025
Actual $33.537B
vs Est $33.512B
▲ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
